Pre-Made Naptumomab Estafenatox biosimilar, Fusion Protein, Naptumomab-Anti-TPBG Antibody: Anti-5T4/5T4AG/M6P1/WAIF1 therapeutic antibody fused with Staphylococcus aureus enterotoxin E SEA/E120 superantigen (synthetic) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-INN-923

Pre-Made Naptumomab Estafenatox biosimilar, Fusion Protein, Naptumomab-Anti-TPBG Antibody: Anti-5T4/5T4AG/M6P1/WAIF1 therapeutic antibody fused with Staphylococcus aureus enterotoxin E SEA/E120 superantigen (synthetic) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

VH, VL: variable (antigen binding) domains of antibody fragment CH1, CL: constant domains of antibody fragment

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-INN-923-1mg 1mg 3090
GMP-Bios-INN-923-10mg 10mg Inquiry
GMP-Bios-INN-923-100mg 100mg Inquiry
GMP-Bios-INN-923-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Naptumomab Estafenatox biosimilar, Fusion Protein, Naptumomab-Anti-TPBG Antibody: Anti-5T4/5T4AG/M6P1/WAIF1 therapeutic antibody fused with Staphylococcus aureus enterotoxin E SEA/E120 superantigen (synthetic)
INN Name Naptumomab Estafenatox
TargetTPBG
FormatFusion Protein
DerivationMus musculus
Species Reactivityhuman
CH1 IsotypeFab - G1 - kappa
VD LCFab - G1 - kappa
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
CompaniesActive Biotech AB (Lund Sweden)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech0